What are the opening hours?

Monday 9am - 1pm 2pm - 6pm Tuesday 9am - 1pm 2pm - 6pm Wednesday 9am - 1pm 2pm - 6pm Thursday 9am - 1pm 2pm - 6pm Friday 9am - 1pm 2pm - 6pm

The Higher Care Clinic

Home
United States
Tulsa, OK
The Higher Care Clinic

THC2 provides OMMA/DHSS physician recommendations in Oklahoma & Missouri. Our team focuses on education, compliance, and patient-centered care.

Appointments available in person and online. Other services include oxygen therapy & state portal assistance

04/07/2026

Applying to be a caregiver is a completely separate process from applying as a patient.

Even if a patient is approved, a caregiver must submit their own application, provide required documentation, and receive independent approval from the state.

This means a caregiver cannot legally assist until their application is fully approved.

Understanding this distinction can help prevent delays and confusion during the application process.

Need help with both applications? We can guide you through each step.

📍 Oklahoma: 918-619-9393
📍 Missouri: 417-290-9333
🌐 https://thc2.com

04/06/2026

A caregiver license allows a designated individual to assist a registered patient with purchasing, transporting, and managing their products in accordance with state guidelines.

This is often used for minors or patients who need additional support.

Caregiver requirements and responsibilities vary by state, so it’s important to understand the application process and documentation involved.

If you’re considering becoming a caregiver, we can help walk you through the steps.

📍 Oklahoma: 918-619-9393
📍 Missouri: 417-290-9333
🌐 https://thc2.com

04/05/2026

Approval timelines can vary, but most patients receive a decision within two weeks after submitting a complete application.

Processing times may be longer during high-volume periods or system updates, so accuracy at submission is key to avoiding additional delays.

Submitting a complete and correct application helps keep everything on track.

Have questions about timelines or your application status? We can help.

📍 Oklahoma: 918-619-9393
📍 Missouri: 417-290-9333
🌐 https://thc2.com

04/04/2026

Application rejections are more common than people think, and in many cases, they’re fixable.

If your application is rejected, the state will typically provide a reason so you can correct the issue and resubmit within the allowed timeframe. Common issues include missing information, incorrect uploads, or photo errors.

Getting it right the first time can help avoid delays and keep your process moving smoothly.

Need help with your application or resubmission? We’re here to guide you through each step.

📍 Oklahoma: 918-619-9393
📍 Missouri: 417-290-9333
🌐 https://thc2.com

04/03/2026

CBD (cannabidiol) is a non-intoxicating cannabinoid and one of the most widely studied compounds.

Current research is exploring how CBD interacts with neurological signaling pathways, including those related to seizure activity, stress response, and mood-related neurotransmitters. Studies have also examined its role in inflammation and pain-related signaling, brain recovery in research models, and receptor activity linked to appetite and nausea.

CBD has been extensively studied compared to many other cannabinoids, though research is still ongoing and continues to evolve across multiple areas of interest.

Education is key when navigating your options.

📍 Oklahoma: (918) 619-9393
📍 Missouri: (417) 290-9333
🌐 https://thc2.com

Contact our team or schedule your evaluation today.

04/02/2026

CBC (cannabichromene) is a non-intoxicating cannabinoid that continues to be studied for its role in multiple biological pathways.

Current research is exploring how CBC may be involved in cellular signaling related to inflammation and pain perception, as well as how it interacts with other cannabinoids in synergy studies. Laboratory findings have also examined its role in oxidative stress response, neurotransmitter activity, and sebaceous gland function in skin-related research.

CBC is considered an area of growing interest, particularly in understanding how cannabinoids work together within the body. Most available data is based on early-stage and preclinical studies, with more research still needed.

Understanding these compounds starts with education.

📍 Oklahoma: (918) 619-9393
📍 Missouri: (417) 290-9333
🌐 https://thc2.com

Contact our team or schedule your evaluation today.

04/01/2026

CBG (cannabigerol) is a non-intoxicating cannabinoid often referred to as a “parent cannabinoid” because it serves as a precursor in the formation of other cannabinoids.

Current research is exploring how CBG interacts with vascular and ocular signaling pathways, as well as its potential role in neuroprotective mechanisms observed in laboratory settings. Preclinical studies have also examined antimicrobial activity, cellular behavior in controlled models, and signaling related to appetite and smooth muscle function, including bladder activity.

Most findings on CBG come from early-stage and preclinical research, meaning more large-scale human studies are still needed to fully understand its effects.

Understanding the science helps you make informed decisions about your care.

📍 Oklahoma: (918) 619-9393
📍 Missouri: (417) 290-9333
🌐 https://thc2.com

Contact our team or schedule your evaluation today.

03/31/2026

CBDV (cannabidivarin) is a non-intoxicating cannabinoid that continues to be studied for its potential role in neurological and physiological processes.

Current research is exploring how CBDV interacts with signaling pathways related to brain excitability, as well as its influence on receptors involved in appetite and nausea regulation. Preclinical studies have also examined its role in neuromuscular signaling, inflammatory responses, and motor function.

CBDV shares structural similarities with CBD, and researchers are studying how these similarities may impact its biological activity and interaction within the body.

This cannabinoid is considered an active area of research, particularly in neuroscience, though findings are still evolving and largely based on early-stage and laboratory data.

Education matters when it comes to understanding your options.

📍 Oklahoma: (918) 619-9393
📍 Missouri: (417) 290-9333
🌐 https://thc2.com

Reach out to our team or schedule your evaluation today.

03/30/2026

CBGV (cannabigerivarin) is a minor cannabinoid that is currently being explored in early-stage research.

Emerging studies are examining how CBGV may interact with inflammatory signaling pathways, immune system communication, and neurological activity. Preclinical models have also looked at its role in seizure-related research, cellular growth behavior, and how it may influence the way other cannabinoids interact within the body.

Researchers are also studying the broader concept of cannabinoid synergy, including how compounds like CBGV may contribute to combined effects when present alongside other cannabinoids.

Like many lesser-known cannabinoids, most available data on CBGV comes from laboratory and preclinical research, not large-scale human trials.

Staying informed helps you make better decisions about your care.

📍 Oklahoma: (918) 619-9393
📍 Missouri: (417) 290-9333
🌐 https://thc2.com

Contact our team or schedule your evaluation today.

03/29/2026

CBCV (cannabichromevarin) is a lesser-studied cannabinoid currently being explored in early-stage research.

Current studies are focused on how CBCV may interact with the body’s internal regulatory system, including pathways related to mood, inflammation signaling, and neurological function. Early laboratory findings are also examining antimicrobial activity and cellular behavior in controlled research models.

Because CBCV research is still in early phases, most available data comes from preclinical and laboratory studies, not large-scale human trials.

If you’re a current patient or exploring your options, staying informed is key.

📍 Oklahoma: (918) 619-9393
📍 Missouri: (417) 290-9333
🌐 https://thc2.com

Schedule your evaluation or reach out to our team for guidance today.

03/28/2026

Details matter.

Accurate paperwork and complete submissions help avoid delays and keep everything moving.

Our team walks you through each step so nothing gets missed.

If you need help with your application or renewal, reach out and we’ll get you started.

thc2.com
📞 OK: 918.619.9393
📞 MO: 417.290.9333

03/27/2026

Appointments include time to go over questions and make sure everything is clear before you leave.

No rushed visits, no confusion about next steps.

If you want a process that’s explained clearly from start to finish, schedule your visit.

thc2.com
📞 OK: 918.619.9393
📞 MO: 417.290.9333

Address

Tulsa, OK

Opening Hours

Monday	9am - 1pm
	2pm - 6pm
Tuesday	9am - 1pm
	2pm - 6pm
Wednesday	9am - 1pm
	2pm - 6pm
Thursday	9am - 1pm
	2pm - 6pm
Friday	9am - 1pm
	2pm - 6pm

Website

https://linktr.ee/TheHighercareclinicthc2, http://thc2.com/

Alerts

Be the first to know and let us send you an email when The Higher Care Clinic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Higher Care Clinic:

Shortcuts

Featured

Gary L. Jones, Ph.D. PLLC
7136 South Yale Avenue
Layrek Clinical Research
10505 E. 91st Street, Suite 202